Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

August 31, 2017

Conditions

Essential Arterial Hypertension

Interventions

DRUG

Candesartan + Chlorthalidone

DRUG

Candesartan + Chlorthalidone

DRUG

Losartan+hydrochlorothiazide